Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer of the PROSTATE”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT07500701
What this trial is testing

Salvage Moderate Hypofractionated Versus Ultrahypofractionated Radiotherapy for Biochemical Recurrence After Radical Prostatectomy in Prostate Cancer

Who this might be right for
Prostate Cancer
Samsung Medical Center 270
Testing effectiveness (Phase 2)Study completedNCT00090545
What this trial is testing

A Phase II Study of BAY 43-9006 (Sorafenib) in Metastatic, Androgen-Independent Prostate Cancer

Who this might be right for
Prostate Cancer
National Cancer Institute (NCI) 46
Not applicableStudy completedNCT02061345
What this trial is testing

PET Imaging in MCI Following ADT for PCa

Who this might be right for
Prostate CancerMild Cognitive Impairment
Imperial College London 11
Testing effectiveness (Phase 2)Looking for participantsNCT07224009
What this trial is testing

Low Dose Naltrexone (LDN) for Management of Fatigue in Prostate Cancer Patients on Androgen Deprivation Therapy (ADT)

Who this might be right for
Metastatic Prostate Cancer
University of Arkansas 60
Not applicableLooking for participantsNCT06335914
What this trial is testing

Dual PSMA and FDG PET Imaging for Patients With Advanced Prostate Cancer

Who this might be right for
Advanced Prostate Cancer
University Health Network, Toronto 30
Testing effectiveness (Phase 2)UnknownNCT03080116
What this trial is testing

Neoadjuvant Degarelix With or Without Apalutamide (ARN-509) Followed by Radical Prostatectomy

Who this might be right for
Prostate CancerNeoadjuvant TherapyAndrogen Antagonists+1 more
Universitaire Ziekenhuizen KU Leuven 90
Very early researchUnknownNCT05955677
What this trial is testing

Head-to-head Comparison of [68Ga]Ga-PSMA-D5 With [68Ga]Ga-PSMA-11 PET/CT in PCa Diagnosis, Recurrence, and Metastasis

Who this might be right for
Prostate CancerPET/CT
Anhui Provincial Hospital 100
Not applicableStudy completedNCT02034812
What this trial is testing

Decision Impact Study to Measure the Influence of DECIPHER on Treatment Recommendations for Radiation Oncologists

Who this might be right for
Prostate Cancer
GenomeDx Biosciences Corp 25
Not applicableUnknownNCT03580109
What this trial is testing

Spa Therapy for Upper or Lower Limb Lymphoedema

Who this might be right for
LymphoedemaBreast CancerMalignant Disease+3 more
Association Francaise pour la Recherche Thermale 160
Testing effectiveness (Phase 2)Active Not RecruitingNCT03444844
What this trial is testing

Biodistribution and Dosimetry of Ga-68 P16-093 in Prostate Cancer

Who this might be right for
Prostate Cancer RecurrentProstate Cancer
Five Eleven Pharma, Inc. 60
Not applicableWithdrawnNCT03970863
What this trial is testing

Focal Therapy for Localized Prostate Cancer

Who this might be right for
Prostate Cancer
China Medical University Hospital
Testing effectiveness (Phase 2)UnknownNCT05327621
What this trial is testing

Pamiparib in mCRPC With HRD or BRCA1/2 Mutation

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Sun Yat-sen University 50
Testing effectiveness (Phase 2)Study completedNCT00193193
What this trial is testing

Weekly Paclitaxel, Low-Dose Estramustine, and Carboplatin in the Treatment of Hormone Refractory Prostate Carcinoma

Who this might be right for
Prostate Cancer
SCRI Development Innovations, LLC 100
Large-scale testing (Phase 3)Looking for participantsNCT05939414
What this trial is testing

An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.

Who this might be right for
Oligometastatic Prostate Cancer (OMPC)
Novartis Pharmaceuticals 450
Not applicableStudy completedNCT03211104
What this trial is testing

Comparison of Duration of Treatment Interruption With or Without Curcumin During the Off Treatment Periods in Patients With Prostate Cancer Undergoing Intermittent Androgen Deprivation Therapy

Who this might be right for
Prostate Cancer
Samsung Medical Center 107
Testing effectiveness (Phase 2)Ended earlyNCT02565901
What this trial is testing

Sirolimus, Docetaxel, and Carboplatin in Treating Patients With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Castration-Resistant Prostate CarcinomaMetastatic Prostate CarcinomaStage IV Prostate Cancer AJCC v7+1 more
University of Washington 28
Not applicableStudy completedNCT00339664
What this trial is testing

Analyses of Human Samples Collected in Clinical Trials

Who this might be right for
Leukemia, MyeloidNeoplasm MetastasisLeukemia, Lymphoid+1 more
National Cancer Institute (NCI) 2,579
Not applicableUnknownNCT00982098
What this trial is testing

Prevention of Urinary Incontinence After Prostatectomy

Who this might be right for
Urinary Incontinence
Azienda Ospedaliero Universitaria Maggiore della Carita 110
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07466498
What this trial is testing

Estrogen to Improve Quality of Life for Men With Newly Diagnosed or Recurrent Metastatic Hormone Sensitive Prostate Cancer, EQUIP Trial

Who this might be right for
Castration-Sensitive Prostate AdenocarcinomaMetastatic Castration-Sensitive Prostate AdenocarcinomaStage IVB Prostate Cancer AJCC v8
Fred Hutchinson Cancer Center 60
Testing effectiveness (Phase 2)Ended earlyNCT03177187
What this trial is testing

Combination Study of AZD5069 and Enzalutamide.

Who this might be right for
Metastatic Castration Resistant Prostate Cancer
Institute of Cancer Research, United Kingdom 30
Next Page